From the Journals

Clinician experience, life stressors drive HIV adherence, retention in new patients


 

FROM AIDS AND BEHAVIOR

Approach matters

“The [study] really hits the nail on the head in terms of identifying a couple of these very salient issues that affect people’s care, especially concerning HIV,” Philip A. Chan, MD, infectious disease specialist and associate professor of medicine at Brown University, Providence, R.I, told this news organization.

“It highlights things that we see on the ground that can interfere with HIV care or [pre-exposure prophylaxis] care, just health care in general, certainly one’s relationship with the physician or provider, and also, you know, real-life stressors,” said Dr. Chan, who was not involved with the study.

Relationship building is especially important for historically underserved populations, a point that’s hardly lost on either Dr. Chan or Dr. Guajardo, who both pointed to higher levels of mistrust among certain patient populations because of their mistreatment by the health care system. The answer? Let the patient lead the initial discussion, allow them to feel comfortable and participate in their care in ways that are most beneficial to them.

“There’s so much miscommunication, misunderstanding, and stigma related to HIV out in the community. So, it’s important to really open the floor for whatever they want to talk about first, before I push any agenda on a new patient.” Dr. Guajardo said. Thereafter, he relies on open-ended questions such as ‘tell me about your sexual partners?’ or ‘what sort of sexual practices do you engage in?’

“At the end of the day, you just need someone dedicated, who can be respectful and listening and caring, and dedicate time to patients to help keep them in care, to listen, and to navigate our incredibly, incredibly complex health care system,” Dr. Chan added.

This study was partly supported by use of the facilities and resources of the Houston Veterans Affairs Center for Innovations in Quality, Effectiveness, and Safety and Harris Health System. Support for the study was also provided by the National Institute of Mental Health and the University of Texas MD Anderson Foundation Chair at Baylor College of Medicine. Dr. Guajardo and Dr. Chan disclosed no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

NIH on HIV vaccine failure: ‘Get your HIV-negative, at-risk patients on PrEP tomorrow’
Federal Practitioner
Updates to CDC’s STI guidelines relevant to midlife women too
Federal Practitioner
ANCHOR study findings may usher in new care standards for anal cancer in HIV-infected patients
Federal Practitioner
More than half of people living with HIV have coronary plaque
Federal Practitioner
In the military, Latino and Black MSM receive more PrEP prescriptions than White counterparts
Federal Practitioner
HIV services are bouncing back from COVID-19 disruptions, data suggest, but recovery is ‘precarious’
Federal Practitioner
New HIV PrEP guidelines call for clinicians to talk to patients about HIV prevention meds
Federal Practitioner
Inadequate routine diabetes screening common in HIV
Federal Practitioner
HIV testing dips during pandemic raise transmission concerns
Federal Practitioner
FDA approves cabotegravir LA; New HIV PrEP option fills an important gap
Federal Practitioner